STRS Ohio’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

STRS Ohio’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,900	Closed	-$130K	–	2104
2022 Q3	$130K	Hold	28,900	–	–	﹤0.01%	1708
2022 Q2	$115K	Hold	28,900	–	–	﹤0.01%	1740
2022 Q1	$211K	Hold	28,900	–	–	﹤0.01%	1696
2021 Q4	$162K	Hold	28,900	–	–	﹤0.01%	1791
2021 Q3	$184K	Hold	28,900	–	–	﹤0.01%	1797
2021 Q2	$243K	Buy	28,900 +18,000	+165%	+$145K	﹤0.01%	1757
2021 Q1	$114K	Hold	10,900	–	–	﹤0.01%	1919
2020 Q4	$184K	Hold	10,900	–	–	﹤0.01%	1764
2020 Q3	$139K	Hold	10,900	–	–	﹤0.01%	1756
2020 Q2	$153K	Buy	+10,900	New	+$138K	﹤0.01%	1696

Other funds holding PRVB

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

STRS Ohio's PRVB Position: Q4 2022 in Review

STRS Ohio sold out of Provention Bio, Inc. Common Stock (PRVB) in Q4 2022, closing a stake of 28,900 shares — an estimated $130K sold.

STRS Ohio first reported a position in PRVB in Q2 2020 and held it in 10 quarters. The position peaked at $243K in Q2 2021. 133 funds tracked by Wall St. Rank hold PRVB as of Q4 2022.

STRS Ohio reported no remaining Provention Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
STRS Ohio sold 28,900 Provention Bio, Inc. Common Stock shares in Q4 2022, an estimated $130K.
STRS Ohio first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
STRS Ohio's Provention Bio, Inc. Common Stock position peaked at $243K in Q2 2021.
133 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.